Angi Inc. Earnings Release Available on Company’s Website
DENVER, Feb. 13, 2024 (GLOBE NEWSWIRE) — Angi Inc. (NASDAQ: ANGI) posted its fourth quarter financial results on the investor […]
Normandy Homes Partners with Operation Finally Home to Deliver Mortgage-Free Home for Veteran in Celina, Texas
PLANO, Texas, Feb. 13, 2024 (GLOBE NEWSWIRE) — U.S. Marine Corps Corporal Neftali “Nef” Mendoza and his family received the […]
Triumph Financial Appoints Michelle Holmes to Chief Marketing Officer
DALLAS, Feb. 13, 2024 (GLOBE NEWSWIRE) — Triumph Financial, Inc. (the “Company”) (Nasdaq: TFIN), a financial holding company focused on […]
Superior Group of Companies Announces Board Observer Program
– Designed to Expose Traditionally Underrepresented Groups to Public Company Corporate Governance – – Kelly Richmond Pope Named First Participant […]
Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones
Term loan agreement enables Company to accelerate development and enhance commercialization of ECO Synthesis™ manufacturing platform for RNAi therapeutics Financing bolsters […]
CNB Financial Corporation Announces Quarterly Dividend for Common Stock
CLEARFIELD, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) — The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) declared a […]
BlackLine Announces Fourth Quarter and Full Year 2023 Financial Results
LOS ANGELES, Feb. 13, 2024 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL), today announced financial results for the fourth quarter […]
SiTime Reports Fourth Quarter 2023 Financial Results
SANTA CLARA, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) — SiTime Corporation, (Nasdaq: SITM), the precision timing company, today announced financial […]
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024
ROCKVILLE, Md., Feb. 13, 2024 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and […]
Telomir Pharmaceuticals Announces Closing of Initial Public Offering
BALTIMORE, Feb. 13, 2024 (GLOBE NEWSWIRE) — Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) (“Telomir” or the “Company”), a pre-clinical-stage pharmaceutical company […]
